• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

Fitbit Charge 3 Now Available to Eligible UnitedHealthcare Motion Participants

by Fred Pennic 05/14/2019 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Fitbit Charge 3 Now Available to Eligible UnitedHealthcare Motion Participants

Wearable fitness leader Fitbit today announce the next phase of its integration with UnitedHealthcare Motion by offering Fitbit Charge 3 as a buy-up option to eligible program participants. Fitbit Inspire HR™, Fitbit’s first device designed to meet the specific needs of the healthcare industry, will also be offered to program participants later this year. This integration builds on Fitbit’s history of working with UnitedHealthcare; Charge 2 was the first wearable device offered as a buy-up option for Motion program participants in 2017.

UnitedHealthcare Motion Program Background

UnitedHealthcare Motion is an employer-sponsored wearable device walking program that encourages participants to move more and monitor their activity levels, with the potential to earn more than $1,000 per year by meeting certain daily walking goals. The program is available for purchase by employers of all sizes across the country, enabling participants to earn a quarterly incentive that is deposited into health reimbursement accounts (HRAs) or health savings accounts (HSAs), as applicable.

Benefits of Integration

The addition of Charge 3 builds on Fitbit’s history of working with UnitedHealthcare to help eligible program participants monitor progress toward daily walking goals from the wrist. Charge 2 was the first wearable device offered as a buy-up option for UnitedHealthcare Motion program participants in 2017. Charge 3 is now available for purchase to UnitedHealthcare Motion program participants; those who already own the device can also use it as part of the program. Later this year, Fitbit Inspire HRTM, Fitbit’s lower priced and stylish device designed to meet the needs of the healthcare industry is also expected to be offered to UnitedHealthcare Motion program participants.

UnitedHealthcare Motion Program Success

On average, active UnitedHealthcare Motion participants log nearly 12,000 steps per day, more than double the number of the average American adult. To date, program participants have walked a combined 272 billion steps and earned more than $43 million in incentives.

“Digital health solutions such as UnitedHealthcare Motion offer valuable and measurable benefits to help motivate and engage people to take control of their health journey,” said Paul Sterling, vice president of emerging products for UnitedHealthcare. “Wearable device options like the Charge 3 are an important resource to help drive participation and engagement in our program, particularly among people managing chronic conditions.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: digital health, Fitbit, Fitbit Charge 3, UnitedHealthcare, UnitedHealthcare Motion

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |